Thomas E. Chilcott III - 16 Sep 2022 Form 4 Insider Report for THERALINK TECHNOLOGIES, INC. (THER)

Role
Chief Financial Officer
Signature
/s/ Thomas E. Chilcott, III
Issuer symbol
THER
Transactions as of
16 Sep 2022
Transactions value $
$0
Form type
4
Filing time
21 Sep 2022, 17:49:30 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THER Stock Option (right to buy) Award $0 +94,545,096 $0 94,545,096 16 Sep 2022 Common Stock 94,545,096 $0.0036 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 37,818,039 of the stock options will become exercisable upon the filing by the corporation of an S-8 registration statement covering its 2022 Equity Incentive Plan. The remaining 56,727,058 stock options will vest equally on September 1, 2023, September 1 2024, and September 1, 2025.